TITLE
Siomycin A treatment in prostate cancer cell lines PC3 and LNCaP

ORGANISM
Homo sapiens

SUMMARY
Siomycin A treatment in prostate cancer cell lines resulted in a concurrent inhibition of specific cell cycle genes and strongly impaired cell viability.

DESIGN
Illumina microarray experiments were done using PC3 and LNCaP cell lines treated with 0.5 microM Siomaycin A either 24h or 48h in triplicates.

